Skip to Main Content

Good morning, everyone, and how are you today? A bright and shiny sun is enveloping the Pharmalot campus, where the official mascots are fertilizing the newly manicured grounds and the shortest of short people has left for the local schoolhouse. As for us, we are considering our to-do list and brewing a needed cup of stimulation, since we anticipate another busy day. No doubt, you can relate. So time to get cracking. Here are some items of interest to get you started. Have a wonderful day and drop us a line when something interesting arises …

A newly unsealed whistleblower lawsuit accuses AstraZeneca (AZN) of hiring nurses to improperly recommend three of its best-selling drugs to doctors and patients under the guise of education and counseling, Reuters notes. This is the latest whistleblower lawsuit to accuse drug makers of engaging in a form of “white coat marketing” by hiring nurses to provide medical advice related to a drug while effectively acting as sales reps for the companies. Other suits have been filed against AbbVie (ABBV), Gilead Sciences (GILD), Amgen (AMGN), Bayer (BAYRY), and Eli Lilly (LLY).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!